Featured Opinions
Organizing for Digital Health Success
How to align your organizational structure with your digital health strategy.
Considering the factors that will be weighed up by customers for and against changing behavior is crucial to building your brand.
by Jill Donahue
"People don’t buy what you do, they buy why you do it". - Simon Sinek
Real-World Medicine: The Needs in a Real-Patient World
True patient centricity in the real world is about finding a service that is responsive 24/7 to fit with the challenges of daily life.
Pharma's Patient Support: Stuck in the 1950s
by Kevin Dolgin
Why isn't pharma investing to increase patient support effectiveness?
Considerations for Risk Sharing Agreements
There are several important questions that should be asked before entering into RSAs.
Turning around flat or declining sales is no easy task but analytics don't lie.
Growing our Business Faster with One Big Idea
by Jill Donahue
Turning this around starts with serving differently, transforming from product/profit to patient/purpose.
Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America
by Marc Yates
If left untreated, hepatitis C leads to chronic health problems putting a huge strain on national healthcare resources.
Defining brands and why they are critical to success in healthcare.
Pharma Missing Out on Pre-Treatment Services Opportunity
by Jeff Elton
By offering pre-treatment services, pharma can become the "go to" resource from the start of the patient journey.
by Marc Yates
What are the opportunities and challenges for pharma companies wishing to gain a foothold in this oil-rich kingdom?
Key Considerations for Successful Data Collaborations
Why this trend has surfaced and key considerations for pharmaceutical companies actively exploring their own collaborations.
Patients, Promises & Politics: Who Can You Trust?
To whom do we entrust our health decisions?
by Jill Donahue
When we focus on patients first, business follows. The time has come to serve differently.
In Defense of Innovation: Value-Based Reimbursement & Contracting
by Jeff Elton
Value-based reimbursement and contracting will become mainstream as reimbursement authorities move away from ‘cost’ as the focus towards ‘value.’
Examining the Physician’s View of Medication Adherence
Most physicians are likely to overestimate their own patients’ adherence rates, according to a Healthprize survey.
Our new column focuses on building great healthcare brands: strong, tangible brands with a clear purpose, anchored to customer needs and the relevant market.
Take Charge of Your Digital Marketing Once and For All
It took a while, but the pharma industry is finally becoming aware that digital approaches may hold the key to transforming the way they market drugs and interact with their customers.
The Dilemma for MNCs in China: New Technology vs. Old?
Healthcare spending in China has more than doubled from $156bn in 2006 to $357bn in 2011 and is estimated to reach $1tn by 2020 – about 6 per cent of the country’s GDP.
Turkey: Identifying the Growth Drivers
by Marc Yates
What are the drivers of this expansion of private healthcare in Turkey? And what the opportunities and implications for global pharma?
New columnists Tina Boggiano & Doug Haggstrom explore pharma's role in digital health.
Building a High-Performance Organization
One of the eternal questions for leaders is: what makes a High-Performance Organization? Lots of companies claim to be High-Performance Organizations. The real thing is rare, however, and instantly recognizable.
Market Segmentation in the New Healthcare Landscape
In order to remain competitive, pharmaceutical companies must shift their focus to smaller, more targeted patient populations.